COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1Life Healthcare, Inc. | Common | 68269G107 | 536 | 31,266 | SH | | SOLE | | 31,266 | 0 | 0 |
Abbott Laboratories | Common | 002824100 | 76,542 | 791,051 | SH | | SOLE | | 791,051 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 70,707 | 526,842 | SH | | SOLE | | 526,842 | 0 | 0 |
Acadia Healthcare Company, Inc. | Common | 00404A109 | 11,038 | 141,189 | SH | | SOLE | | 141,189 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 1,182 | 72,225 | SH | | SOLE | | 72,225 | 0 | 0 |
Adaptive Biotechnologies Corp. | Common | 00650F109 | 3,007 | 422,281 | SH | | SOLE | | 422,281 | 0 | 0 |
Addus HomeCare Corp. | Common | 006739106 | 7,965 | 83,632 | SH | | SOLE | | 83,632 | 0 | 0 |
Adicet Bio, Inc. | Common | 007002108 | 573 | 40,329 | SH | | SOLE | | 40,329 | 0 | 0 |
Affimed N.V. | Common | N01045108 | 1,207 | 586,038 | SH | | SOLE | | 586,038 | 0 | 0 |
Agilent Technologies, Inc. | Common | 00846U101 | 5,250 | 43,191 | SH | | SOLE | | 43,191 | 0 | 0 |
AlerisLife Inc. | Common | 33832D205 | 23 | 24,237 | SH | | SOLE | | 24,237 | 0 | 0 |
Align Technology, Inc. | Common | 016255101 | 3,913 | 18,894 | SH | | SOLE | | 18,894 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 6,914 | 309,613 | SH | | SOLE | | 309,613 | 0 | 0 |
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 6,527 | 428,580 | SH | | SOLE | | 428,580 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 28,666 | 143,214 | SH | | SOLE | | 143,214 | 0 | 0 |
ALX Oncology Holdings Inc. | Common | 00166B105 | 634 | 66,211 | SH | | SOLE | | 66,211 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 116,953 | 518,869 | SH | | SOLE | | 518,869 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 18,173 | 266,076 | SH | | SOLE | | 266,076 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y506 | 67 | 32,461 | SH | | SOLE | | 32,461 | 0 | 0 |
Arcutis Biotherapeutics, Inc. | Common | 03969K108 | 2,845 | 148,874 | SH | | SOLE | | 148,874 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 642 | 539,408 | SH | | SOLE | | 539,408 | 0 | 0 |
argenx SE | Sponsored ADR | 04016X101 | 27,056 | 76,635 | SH | | SOLE | | 76,635 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 5,185 | 156,875 | SH | | SOLE | | 156,875 | 0 | 0 |
Arvinas, Inc. | Common | 04335A105 | 3,826 | 85,997 | SH | | SOLE | | 85,997 | 0 | 0 |
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 7,000 | 67,794 | SH | | SOLE | | 67,794 | 0 | 0 |
Assertio Holdings, Inc. | Common | 04546C205 | 932 | 410,575 | SH | | SOLE | | 410,575 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 69,822 | 1,273,193 | SH | | SOLE | | 1,273,193 | 0 | 0 |
Avidity Biosciences, Inc. | Common | 05370A108 | 1,055 | 64,618 | SH | | SOLE | | 64,618 | 0 | 0 |
Beam Therapeutics Inc. | Common | 07373V105 | 754 | 15,817 | SH | | SOLE | | 15,817 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 2,825 | 20,952 | SH | | SOLE | | 20,952 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481404 | 7 | 6,000 | SH | | SOLE | | 6,000 | 0 | 0 |
Bicycle Therapeutics PLC | Sponsored ADS | 088786108 | 2,063 | 88,676 | SH | | SOLE | | 88,676 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | Common | 09058V103 | 4,405 | 349,570 | SH | | SOLE | | 349,570 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 38,832 | 145,439 | SH | | SOLE | | 145,439 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd. | Common | G11196105 | 10,609 | 70,176 | SH | | SOLE | | 70,176 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 12,796 | 150,947 | SH | | SOLE | | 150,947 | 0 | 0 |
BioNTech SE | Sponsored ADS | 09075V102 | 12,819 | 95,042 | SH | | SOLE | | 95,042 | 0 | 0 |
Black Diamond Therapeutics, Inc. | Common | 09203E105 | 223 | 131,990 | SH | | SOLE | | 131,990 | 0 | 0 |
Boston Scientific Corp. | Common | 101137107 | 30,799 | 795,215 | SH | | SOLE | | 795,215 | 0 | 0 |
Bristol-Myers Squibb Company | Common | 110122108 | 62,522 | 879,476 | SH | | SOLE | | 879,476 | 0 | 0 |
Cardiovascular Systems, Inc. | Common | 141619106 | 2,424 | 174,859 | SH | | SOLE | | 174,859 | 0 | 0 |
Caribou Biosciences, Inc. | Common | 142038108 | 5,983 | 567,147 | SH | | SOLE | | 567,147 | 0 | 0 |
Cerevel Therapeutics Holdings, Inc. | Common | 15678U128 | 4,987 | 176,483 | SH | | SOLE | | 176,483 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 14,302 | 72,675 | SH | | SOLE | | 72,675 | 0 | 0 |
ChemoCentryx, Inc. | Common | 16383L106 | 4,040 | 78,197 | SH | | SOLE | | 78,197 | 0 | 0 |
Cigna Corp. | Common | 125523100 | 58,472 | 210,731 | SH | | SOLE | | 210,731 | 0 | 0 |
Codexis Inc | Common | 192005106 | 419 | 69,125 | SH | | SOLE | | 69,125 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 190 | 88,335 | SH | | SOLE | | 88,335 | 0 | 0 |
Community Healthcare Trust Inc. | Common | 20369C106 | 488 | 14,900 | SH | | SOLE | | 14,900 | 0 | 0 |
Corbus Pharmaceuticals Holdings, Inc. | Common | 21833P103 | 25 | 154,310 | SH | | SOLE | | 154,310 | 0 | 0 |
CRISPR Therapeutics AG | Namen AKT | H17182108 | 3,599 | 55,080 | SH | | SOLE | | 55,080 | 0 | 0 |
CVS Health Corp. | Common | 126650100 | 11,807 | 123,803 | SH | | SOLE | | 123,803 | 0 | 0 |
Cytokinetics, Inc. | Common | 23282W605 | 3,640 | 75,139 | SH | | SOLE | | 75,139 | 0 | 0 |
Danaher Corp. | Common | 235851102 | 32,172 | 124,556 | SH | | SOLE | | 124,556 | 0 | 0 |
Denali Therapeutics, Inc. | Common | 24823R105 | 6,826 | 222,420 | SH | | SOLE | | 222,420 | 0 | 0 |
Design Therapeutics, Inc. | Common | 25056L103 | 4,690 | 280,523 | SH | | SOLE | | 280,523 | 0 | 0 |
Dexcom, Inc. | Common | 252131107 | 19,790 | 245,712 | SH | | SOLE | | 245,712 | 0 | 0 |
Diversified Healthcare Trust | Common | 25525P107 | 354 | 357,720 | SH | | SOLE | | 357,720 | 0 | 0 |
Edgewise Therapeutics, Inc. | Common | 28036F105 | 1,919 | 195,025 | SH | | SOLE | | 195,025 | 0 | 0 |
Edwards Lifesciences Corp. | Common | 28176E108 | 14,162 | 171,388 | SH | | SOLE | | 171,388 | 0 | 0 |
Elevance Health, Inc. | Common | 036752103 | 6,652 | 14,644 | SH | | SOLE | | 14,644 | 0 | 0 |
Eli Lilly and Company | Common | 532457108 | 77,791 | 240,578 | SH | | SOLE | | 240,578 | 0 | 0 |
Endo International plc | Shares | G30401106 | 48 | 494,607 | SH | | SOLE | | 494,607 | 0 | 0 |
Fulcrum Therapeutics, Inc. | Common | 36118A100 | 474 | 58,537 | SH | | SOLE | | 58,537 | 0 | 0 |
Fusion Pharmaceuticals Inc. | Common | 36118A100 | 131 | 43,394 | SH | | SOLE | | 43,394 | 0 | 0 |
G1 Therapeutics, Inc. | Common | 3621LQ109 | 5,294 | 423,869 | SH | | SOLE | | 423,869 | 0 | 0 |
Galera Therapeutics, Inc. | Common | 36338D108 | 1,563 | 898,374 | SH | | SOLE | | 898,374 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 100,071 | 1,622,165 | SH | | SOLE | | 1,622,165 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 1,490 | 174,897 | SH | | SOLE | | 174,897 | 0 | 0 |
GSK PLC SPON ADR | Common | 37733W204 | 1,232 | 41,852 | SH | | SOLE | | 41,852 | 0 | 0 |
Guardant Health, Inc. | Common | 40131M109 | 18,630 | 346,084 | SH | | SOLE | | 346,084 | 0 | 0 |
Harpoon Therapeutics, Inc. | Common | 41358P106 | 252 | 259,910 | SH | | SOLE | | 259,910 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 22,846 | 124,303 | SH | | SOLE | | 124,303 | 0 | 0 |
Health Care Select Sector SPDR Fund | SBI Healthcare | 81369Y209 | 3,515 | 29,024 | SH | | SOLE | | 29,024 | 0 | 0 |
Healthcare Realty Trust Inc. | Common | 42226K105 | 3,642 | 174,686 | SH | | SOLE | | 174,686 | 0 | 0 |
HealthEquity, Inc. | Common | 42226A107 | 7,403 | 110,214 | SH | | SOLE | | 110,214 | 0 | 0 |
Healthpeak Properties, Inc. | Common | 42250P103 | 3,447 | 150,392 | SH | | SOLE | | 150,392 | 0 | 0 |
Horizon Therapeutics plc | Common | G46188101 | 45,449 | 734,353 | SH | | SOLE | | 734,353 | 0 | 0 |
Humana Inc. | Common | 444859102 | 54,828 | 113,004 | SH | | SOLE | | 113,004 | 0 | 0 |
I-Mab | Sponsored ADS | 44975P103 | 652 | 162,580 | SH | | SOLE | | 162,580 | 0 | 0 |
Icon plc | Shares | G4705A100 | 1,918 | 10,434 | SH | | SOLE | | 10,434 | 0 | 0 |
IDEAYA Biosciences, Inc. | Common | 45166A102 | 1,987 | 133,185 | SH | | SOLE | | 133,185 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 17,661 | 54,207 | SH | | SOLE | | 54,207 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 56,272 | 294,943 | SH | | SOLE | | 294,943 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 8,633 | 154,269 | SH | | SOLE | | 154,269 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 726 | 52,067 | SH | | SOLE | | 52,067 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 8,020 | 172,371 | SH | | SOLE | | 172,371 | 0 | 0 |
Intuitive Surgical, Inc. | Common | 46120E602 | 19,569 | 104,403 | SH | | SOLE | | 104,403 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 3,885 | 87,840 | SH | | SOLE | | 87,840 | 0 | 0 |
IQVIA Holdings Inc. | Common | 46266C105 | 12,284 | 67,817 | SH | | SOLE | | 67,817 | 0 | 0 |
Ishares Biothechnology ETF | Common | 464287556 | 2,874 | 24,569 | SH | | SOLE | | 24,569 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 24,363 | 182,782 | SH | | SOLE | | 182,782 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 128,038 | 783,779 | SH | | SOLE | | 783,779 | 0 | 0 |
Karuna Therapeutics, Inc. | Common | 48576A100 | 5,312 | 23,616 | SH | | SOLE | | 23,616 | 0 | 0 |
Koninklijke Philips N.V. | NY Reg Shares | 500472303 | 2,536 | 164,790 | SH | | SOLE | | 164,790 | 0 | 0 |
Laboratory Corporation of America Holdings | Common | 50540R409 | 9,041 | 44,142 | SH | | SOLE | | 44,142 | 0 | 0 |
Lantheus Holdings, Inc. | Common | 516544103 | 16,118 | 229,179 | SH | | SOLE | | 229,179 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 6,827 | 182,293 | SH | | SOLE | | 182,293 | 0 | 0 |
McKesson Corp. | Common | 58155Q103 | 11,439 | 33,657 | SH | | SOLE | | 33,657 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 4,883 | 411,743 | SH | | SOLE | | 411,743 | 0 | 0 |
Medpace Holdings, Inc. | Common | 58506Q109 | 1,483 | 9,435 | SH | | SOLE | | 9,435 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 26,338 | 326,172 | SH | | SOLE | | 326,172 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 47,549 | 552,122 | SH | | SOLE | | 552,122 | 0 | 0 |
Mereo BioPharma Group plc | ADS | 589492107 | 1,336 | 1,551,082 | SH | | SOLE | | 1,551,082 | 0 | 0 |
Merus N.V. | Common | N5749R100 | 3,389 | 169,207 | SH | | SOLE | | 169,207 | 0 | 0 |
Mirati Therapeutics, Inc. | Common | 60468T105 | 8,548 | 122,390 | SH | | SOLE | | 122,390 | 0 | 0 |
Moderna, Inc. | Common | 60770K107 | 37,240 | 314,924 | SH | | SOLE | | 314,924 | 0 | 0 |
Molina Healthcare, Inc. | Common | 60855R100 | 39,427 | 119,535 | SH | | SOLE | | 119,535 | 0 | 0 |
MoonLake Immunotherapeutics | Common | 61559X104 | 2,388 | 300,000 | SH | | SOLE | | 300,000 | 0 | 0 |
Morphic Holding, Inc. | Common | 61775R105 | 1,263 | 44,625 | SH | | SOLE | | 44,625 | 0 | 0 |
MorphoSys AG | Sponsored ADS | 617760202 | 412 | 81,867 | SH | | SOLE | | 81,867 | 0 | 0 |
Natera, Inc. | Common | 632307104 | 938 | 21,400 | SH | | SOLE | | 21,400 | 0 | 0 |
National Health Investors, Inc. | Common | 63633D104 | 567 | 10,038 | SH | | SOLE | | 10,038 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 17,855 | 168,108 | SH | | SOLE | | 168,108 | 0 | 0 |
NexGel, Inc. | Common | 65344E107 | 6 | 4,243 | SH | | SOLE | | 4,243 | 0 | 0 |
Nkarta, Inc. | Common | 65487U108 | 381 | 28,988 | SH | | SOLE | | 28,988 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 10,354 | 136,225 | SH | | SOLE | | 136,225 | 0 | 0 |
Novavax, Inc. | Common | 670002401 | 1,161 | 63,800 | SH | | SOLE | | 63,800 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 13,004 | 130,523 | SH | | SOLE | | 130,523 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 9,037 | 306,433 | SH | | SOLE | | 306,433 | 0 | 0 |
Option Care Health, Inc. | Common | 68404L201 | 2,045 | 64,975 | SH | | SOLE | | 64,975 | 0 | 0 |
Owens & Minor, Inc. | Common | 690732102 | 5,425 | 225,117 | SH | | SOLE | | 225,117 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 1,827 | 51,224 | SH | | SOLE | | 51,224 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 49,541 | 1,132,103 | SH | | SOLE | | 1,132,103 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 2,538 | 168,741 | SH | | SOLE | | 168,741 | 0 | 0 |
Praxis Precision Medicines, Inc. | Common | 74006W108 | 170 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
Precision BioSciences, Inc. | Common | 74019P108 | 292 | 224,534 | SH | | SOLE | | 224,534 | 0 | 0 |
Prometheus Biosciences, Inc. | Common | 74349U108 | 1,859 | 31,505 | SH | | SOLE | | 31,505 | 0 | 0 |
Protagonist Therapeutics, Inc. | Common | 74366E106 | 1,031 | 122,271 | SH | | SOLE | | 122,271 | 0 | 0 |
Pyxis Oncology, Inc. | Common | 747324101 | 1,395 | 708,303 | SH | | SOLE | | 708,303 | 0 | 0 |
R1 RCM Inc. | Common | 77634L105 | 3,750 | 202,351 | SH | | SOLE | | 202,351 | 0 | 0 |
Rallybio Corporation | Common | 75120L100 | 25,191 | 1,740,931 | SH | | SOLE | | 1,740,931 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 75,130 | 109,062 | SH | | SOLE | | 109,062 | 0 | 0 |
Repare Therapeutics Inc. | Common | 760273102 | 354 | 29,150 | SH | | SOLE | | 29,150 | 0 | 0 |
ResMed Inc. | Common | 761152107 | 13,251 | 60,699 | SH | | SOLE | | 60,699 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 6,700 | 510,660 | SH | | SOLE | | 510,660 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 4,694 | 123,454 | SH | | SOLE | | 123,454 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 18,345 | 165,959 | SH | | SOLE | | 165,959 | 0 | 0 |
Scholar Rock Holding Corp. | Common | 80706P103 | 754 | 108,833 | SH | | SOLE | | 108,833 | 0 | 0 |
Seagen Inc. | Common | 81181C104 | 7,305 | 53,387 | SH | | SOLE | | 53,387 | 0 | 0 |
Smith & Nephew plc | Sponsored ADR | 83175M205 | 4,219 | 181,710 | SH | | SOLE | | 181,710 | 0 | 0 |
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 11,714 | 147,677 | SH | | SOLE | | 147,677 | 0 | 0 |
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 49 | 114,670 | SH | | SOLE | | 114,670 | 0 | 0 |
STERIS plc | Shares | G8473T100 | 2,772 | 16,669 | SH | | SOLE | | 16,669 | 0 | 0 |
Stevanato Group Societa' Per Azioni | Ordinary Shares | T9224W109 | 1,206 | 71,190 | SH | | SOLE | | 71,190 | 0 | 0 |
Stryker Corp. | Common | 863667101 | 39,197 | 193,528 | SH | | SOLE | | 193,528 | 0 | 0 |
Sutro Biopharma, Inc. | Common | 869367102 | 910 | 163,924 | SH | | SOLE | | 163,924 | 0 | 0 |
Takeda Pharmaceutical Company Ltd. | Sponsored ADS | 874060205 | 1,363 | 105,073 | SH | | SOLE | | 105,073 | 0 | 0 |
Terumo Corp. | Common | 688507070 | 487 | 17,288 | SH | | SOLE | | 17,288 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 3,709 | 459,651 | SH | | SOLE | | 459,651 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 47,526 | 93,705 | SH | | SOLE | | 93,705 | 0 | 0 |
Theseus Pharmaceuticals, Inc. | Common | 88369M101 | 580 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Travere Therapeutics, Inc. | Common | 89422G107 | 6,103 | 247,678 | SH | | SOLE | | 247,678 | 0 | 0 |
TScan Therapeutics, Inc. | Common | 89854M101 | 610 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 2,777 | 67,065 | SH | | SOLE | | 67,065 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 9,787 | 521,693 | SH | | SOLE | | 521,693 | 0 | 0 |
United Therapeutics Corp. | Common | 91307C102 | 24,576 | 117,377 | SH | | SOLE | | 117,377 | 0 | 0 |
Unitedhealth Group Inc. | Common | 91324P102 | 138,404 | 274,046 | SH | | SOLE | | 274,046 | 0 | 0 |
Universal Health Realty Income Trust | Common | 91359E105 | 486 | 11,258 | SH | | SOLE | | 11,258 | 0 | 0 |
VectivBio Holding AG | Common | H9060V101 | 4,539 | 756,502 | SH | | SOLE | | 756,502 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 2,679 | 66,681 | SH | | SOLE | | 66,681 | 0 | 0 |
Vertex Pharmaceuticals Inc. | Common | 92532F100 | 90,743 | 313,403 | SH | | SOLE | | 313,403 | 0 | 0 |
VYNE Therapeutics Inc. | Common | 92941V209 | 30 | 135,395 | SH | | SOLE | | 135,395 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 2,668 | 41,484 | SH | | SOLE | | 41,484 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 5,205 | 200,328 | SH | | SOLE | | 200,328 | 0 | 0 |
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 2,229 | 61,733 | SH | | SOLE | | 61,733 | 0 | 0 |
Zai Lab Ltd. | ADR | 98887Q104 | 1,481 | 43,300 | SH | | SOLE | | 43,300 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 27,065 | 258,868 | SH | | SOLE | | 258,868 | 0 | 0 |
Zoetis Inc. | Class A | 98978V103 | 20,303 | 136,914 | SH | | SOLE | | 136,914 | 0 | 0 |